TI-0093

· Therorna

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TI-0093, covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors [Phase 1]